Abstract:Previously, we have demonstrated the antiadipogenic benefits of Ganoderma triterpenoids (GTs), which indicated GTs have potential therapeutic implications for obesity. In this study, the EtOAc extract of Ganoderma applanatum was further phytochemically investigated for searching new antiadipogenic agents, which led to the isolation of a total of 15 highly oxygenated lanostane triterpenoids, including 9 new compounds (1–9) and 6 known analogues (10–15). Structurally, ganodapplanoic acids A and B (1, 2) are two rearranged 6/6/5/6-fused lanostane-type triterpenoids with an unusual C-13/C-15 oxygen bridge moiety. In addition, the EtOAc extract (GAE) and isolates (1–4,6–15) were assayed for their antiadipogenic effects in 3T3-L1 adipocytes. The results revealed that compound 9 effectively repressed adipogenesis through down-regulating the expression of major proteins (PPARγ, CEBPβ and FAS) involving differentiation and adipogenesis in 3T3-L1 adipocytes. Thus, the present study further demonstrated the antiadipogenic potential of GTs and provided a possible perspective for obesity treatment.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to find new antiadipogenic compounds, especially the functional triterpenoids isolated from the medicinal fungus _Ganoderma applanatum_. Through further phytochemical studies, the authors isolated 15 highly oxidized lanostane - type triterpenoids from the ethyl acetate extract of _Ganoderma applanatum_, including 9 new compounds (1 - 9) and 6 known analogs (10 - 15). The structural characteristics and antiadipogenic activities of these compounds were studied in detail to evaluate their potential applications in the treatment of obesity. Specifically, the focus of the paper is as follows: 1. **Isolation and identification of compounds**: 15 triterpenoids were isolated from _Ganoderma applanatum_, and the structures of these compounds were identified by various spectroscopic techniques (such as NMR, MS, etc.). 2. **Antiadipogenic activity test**: Experiments were carried out in 3T3 - L1 pre - adipocytes to evaluate the antiadipogenic effects of these compounds and their extracts. The results showed that compound 9 can effectively inhibit adipogenesis and prevent the differentiation of adipocytes and adipogenesis by down - regulating the expression of key proteins (such as PPARγ, CEBPβ and FAS). 3. **Mechanism research**: Explore how these compounds exert their antiadipogenic effects by regulating the expression of adipogenesis - related proteins, thereby providing a theoretical basis for the further development of anti - obesity drugs. In conclusion, this paper aims to discover and verify new antiadipogenic compounds in _Ganoderma applanatum_ through systematic research, and provide new candidate drugs for the treatment of obesity and related metabolic diseases.

Functional triterpenoids from medicinal fungi Ganoderma applanatum: A continuous search for antiadipogenic agents

Highly oxygenated lanostane triterpenoids from Ganoderma applanatum as a class of agents for inhibiting lipid accumulation in adipocytes

Anti-Adipogenic Lanostane-Type Triterpenoids from the Edible and Medicinal Mushroom Ganoderma applanatum

Identification of a Novel Metabolic Target for Bioactive Triterpenoids Biosynthesis in <i>Ganoderma</i> lucidum

Triterpenoids from functional mushroom Ganoderma resinaceum and the novel role of Resinacein S in enhancing the activity of brown/beige adipocytes

FPR2-based anti-inflammatory and anti-lipogenesis activities of novel meroterpenoid dimers from Ganoderma

Lanostane Triterpenes from the Tibetan Medicinal Mushroom Ganoderma leucocontextum and Their Inhibitory Effects on HMG-CoA Reductase and α-Glucosidase

New lanostane-type triterpenoids with proangiogenic activity from the fruiting body of Ganoderma applanatum

Triterpenoids and meroterpenoids with α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma australe

New Lanostane-Type Triterpenoids from the Fruiting Body of Ganoderma Hainanense

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

Twelve undescribed derivatives of ganoderic acid isolated from Ganoderma luteomarginatum and their cytotoxicity against three human cancer cell lines

Antidiabetic lanostane triterpenoids from the fruiting bodies of Ganoderma weberianum

Lanostane triterpenoids with anti-proliferative and PTP1B/α-glucosidase inhibitory activities from the fruiting bodies of Ganoderma calidophilum

Novel Ganoderma triterpenoid saponins from the biotransformation-guided purification of a commercial Ganoderma extract

Spiroganodermaines A−G from Ganoderma species and their activities against insulin resistance and renal fibrosis

Lanostane triterpenoids from Ganoderma lucidum and their inhibitory effects against FAAH

Triterpenes and meroterpenes from Ganoderma lucidum with inhibitory activity against HMGs reductase, aldose reductase and α-glucosidase

Lanostane triterpenoids from the fruiting bodies of Ganoderma amboinense

Anti-adipogenicadamantane type polycyclic polyprenylated acylphloroglucinols from Hypericum subsessile

Lanostane triterpenoids with anti-proliferative and anti-inflammatory activities from medicinal mushroom Ganoderma lingzhi